Table 2.
Descriptive statistics for subjects that completed the study (N = 99).
| Variable | All Subjects | Treatment A | Treatment B | Treatment C | Treated Subjects (A + B + C) | Control Group (D) | |
|---|---|---|---|---|---|---|---|
| N (%) | 99 | 22 (22.2) | 26 (26.3) | 26 (26.3) | 74 (74.7) | 25 (25.2) | |
| Age (SD) | 37 (11) | 38 (12) | 35 (10) | 36 (11) | 36 (11) | 41 (11) | |
| Gender (%) | Male | 54 (53.5) | 11 (50.0) | 13 (50.0) | 14 (53.8) | 38 (51.4) | 14 (56.0) |
| Female | 47 (46.5) | 11 (50.0) | 13 (50.0) | 12 (46.2) | 36 (48.6) | 11 (44.0) | |
| BMI *(SD) | 25.0 (4.2) | 26 (4.8) | 23.7 (3.9) | 24.8 (4.6) | 24.8 (4.5) | 25.8 (3.3) | |
| 25-OH-VitD conc. Avg ± SD (nmol/L) | Baseline | 39.5 (5.5) | 39.5 (4.8) | 39.5 (5.5) | 39.0 (5.3) | 39.3 (5.5) | 39.5 (6.3) |
| Intervention | 60.3 (21.0) | 70.8 (20.3) | 69.0 (19.3) | 66.0 (13.0) | 68.5 (17.5) | 35.8 (6.5) |
Notes: * BMI: data missing for one subject in group A; treatments: A—vitamin D capsules with starch-adsorbed vitamin D; B—oil-based Valens vitamin D oral spray; C—water-based Valens vitamin D oral spray; and D—control group.